HOSPITAL BURDEN OF DISEASE ASSOCIATED WITH METASTATIC BONE DISEASE (MBD) AND SKELETAL-RELATED EVENTS (SRES) IN PATIENTS WITH BREAST CANCER (BC) AND PROSTATE CANCER (PC) IN THE UNITED KINGDOM (UK)

被引：1
|
作者：
Oglesby, A. [1 ]
Pockett, R. D. [2 ]
McEwan, P. [2 ]
Chung, K. [1 ]
机构：
[1] Amgen Inc, Thousand Oaks, CA 91320 USA
[2] Cardiff Res Consortium, Cardiff, S Glam, Wales
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)66590-4
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A476 / A476
页数：1
相关论文
共 50 条
  • [1] HOSPITAL BURDEN OF DISEASE ASSOCIATED WITH METASTATIC BONE DISEASE (MBD) AND SKELETAL-RELATED EVENTS (SRES) IN PATIENTS WITH BREAST CANCER (BC) AND PROSTATE CANCER (PC) IN SPAIN
    Oglesby, A.
    Pockett, R. D.
    McEwan, P.
    Chung, K.
    VALUE IN HEALTH, 2008, 11 (06) : A477 - A477
  • [2] The hospital burden of disease associated with bone metastases and skeletal-related events in patients with breast cancer, lung cancer, or prostate cancer in Spain
    Pockett, R. D.
    Castellano, D.
    McEwan, P.
    Oglesby, A.
    Barber, B. L.
    Chung, K.
    EUROPEAN JOURNAL OF CANCER CARE, 2010, 19 (06) : 755 - 760
  • [3] Risk of skeletal-related events (SREs) in patients with breast cancer (BC) and newly diagnosed metastases to bone.
    Taneja, Charu
    Lamerato, Lois
    Glass, Andrew
    Richert-Boe, Kathryn E.
    Edelsberg, John
    Wolff, Greg G.
    Czapski, Natalie
    Chung, Karen
    Richhariya, Akshara
    Oster, Gerry
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [4] Risk of skeletal-related events (SREs) in patients with breast cancer (BC) and newly diagnosed metastases to bone.
    Taneja, Charu
    Lamerato, Lois
    Glass, Andrew
    Richert-Boe, Kathryn E.
    Edelsberg, John
    Wolff, Greg G.
    Czapski, Natalie
    Chung, Karen
    Richhariya, Akshara
    Oster, Gerry
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] Risk of skeletal-related events (SREs) in patients with prostate cancer (PC) and newly diagnosed metastases to bone.
    Glass, Andrew
    Lamerato, Lois
    Edelsberg, John
    Richert-Boe, Kathryn E.
    Taneja, Charu
    Wolff, Greg G.
    Czapski, Natalie
    Chung, Karen
    Richhariya, Akshara
    Oster, Gerry
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] Health care utilization and costs associated with skeletal-related events (SREs) in patients with breast cancer (BC) and bone metastases (BMets).
    Hagiwara, May
    Chung, Karen
    Delea, Thomas E.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [7] Efficacy of ibandronate for the prevention of skeletal-related events in breast cancer patients with metastatic bone disease
    Heras, P.
    Hatzopoulos, A.
    Mitsibounas, D.
    EJC SUPPLEMENTS, 2005, 3 (02): : 121 - 121
  • [8] The burden of skeletal-related events in patients with prostate cancer and bone metastasis
    Roghmann, Florian
    Antczak, Carina
    McKay, Rana R.
    Choueiri, Toni
    Hu, Jim C.
    Kibel, Adam S.
    Kim, Simon P.
    Kowalczyk, Keith J.
    Menon, Mani
    Nguyen, Paul L.
    Saad, Fred
    Sammon, Jesse D.
    Schmid, Marianne
    Sukumar, Shyam
    Sun, Maxine
    Noldus, Joachim
    Quoc-Dien Trinh
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (01) : 17.e9 - 17.e18
  • [9] Prognostic variables for occurrence of skeletal-related events (SREs) in patients with breast cancer metastatic to bone: A multivariate analysis
    Brown, Janet
    Cook, Richard
    Coleman, Robert
    CANCER TREATMENT REVIEWS, 2008, 34 : S79 - S79
  • [10] Denosumab for the prevention of symptomatic skeletal events (SSEs) in patients with bone-metastatic breast cancer: A comparison with skeletal-related events (SREs)
    Body, J-J.
    von Moos, R.
    Lipton, A.
    Martin, M.
    Diel, I.
    Steger, G.
    Tonkin, K.
    de Boer, R.
    Radcliffe, H-S.
    Niepel, D.
    Stopeck, A. T.
    ANNALS OF ONCOLOGY, 2016, 27
12345